Commonwealth Retirement Investments LLC Buys Shares of 4,849 Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Commonwealth Retirement Investments LLC purchased a new position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 4,849 shares of the company’s stock, valued at approximately $401,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in PJP. FMR LLC grew its stake in Invesco Pharmaceuticals ETF by 29.4% during the 3rd quarter. FMR LLC now owns 1,057 shares of the company’s stock worth $92,000 after buying an additional 240 shares during the last quarter. Howe & Rusling Inc. acquired a new stake in Invesco Pharmaceuticals ETF in the third quarter worth about $48,000. Joseph Group Capital Management boosted its holdings in Invesco Pharmaceuticals ETF by 16.0% in the third quarter. Joseph Group Capital Management now owns 15,080 shares of the company’s stock worth $1,312,000 after acquiring an additional 2,079 shares in the last quarter. MGB Wealth Management LLC grew its stake in shares of Invesco Pharmaceuticals ETF by 11.9% during the fourth quarter. MGB Wealth Management LLC now owns 21,976 shares of the company’s stock worth $1,815,000 after acquiring an additional 2,345 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of Invesco Pharmaceuticals ETF by 241.7% during the third quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock valued at $352,000 after acquiring an additional 2,862 shares in the last quarter.

Invesco Pharmaceuticals ETF Stock Up 0.1 %

PJP stock opened at $86.66 on Tuesday. The stock has a market capitalization of $264.31 million, a PE ratio of 24.54 and a beta of 0.58. Invesco Pharmaceuticals ETF has a 52 week low of $75.33 and a 52 week high of $89.87. The firm has a 50 day moving average of $84.40 and a 200 day moving average of $85.92.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.